Medicine
Tizanidine 2 mg tablet
Tizanidine 2 mg tablet is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Tizanidine
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 500 tablets, 150 tablets, 1000 tablets and 155 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaUnichem LaboratoriesIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaBryant Ranch PrepackApotexRising Pharma Holdings30 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03BX02 Tizanidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 July 2002
- Identifiers
- RxCUI 313412, 313413DailyMed set ID e13292b0-9858-4405-8787-a2392d1b6d75, afc90292-c6bf-2d96-e053-2995a90abf00, 3670f9e3-988d-48e6-9df0-d403d699e08a +37NDC 71335-1799, 80425-0425, 68084-775 +37Application ANDA076416, ANDA076286, ANDA076282 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 30 labelers. The register lists 158 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 tablet in 1 bottle | 67877-613-05 | Ascend LaboratoriesIndia | 27 January 2019 |
| 150 tablet in 1 bottle | 67877-613-15 | Ascend LaboratoriesIndia | 27 January 2019 |
| 150 tablet in 1 bottle | 84386-023-77 | Aurobindo PharmaIndia | 1 September 2026 |
| 1000 tablet in 1 bottle | 84386-023-99 | Aurobindo PharmaIndia | 1 September 2026 |
| 300 tablet in 1 bottle | 55111-179-03 | Dr. Reddy's LaboratoriesIndia | 3 July 2002 |
| 1000 tablet in 1 bottle | 55111-179-10 | Dr. Reddy's LaboratoriesIndia | 3 July 2002 |
| 150 tablet in 1 bottle | 55111-179-15 | Dr. Reddy's LaboratoriesIndia | 3 July 2002 |
| 30 tablet in 1 bottle | 55111-179-30 | Dr. Reddy's LaboratoriesIndia | 3 July 2002 |
| 1000 tablet in 1 bottle | 57664-502-18 | Sun Pharmaceutical IndustriesIndia | 11 December 2003 |
| 150 tablet in 1 bottle | 57664-502-89 | Sun Pharmaceutical IndustriesIndia | 11 December 2003 |
| 500 tablet in 1 bottle, plastic | 29300-168-05 | Unichem LaboratoriesIndia | 1 April 2013 |
| 1000 tablet in 1 bottle, plastic | 29300-168-10 | Unichem LaboratoriesIndia | 1 April 2013 |
| 150 tablet in 1 bottle, plastic | 29300-168-15 | Unichem LaboratoriesIndia | 1 April 2013 |
| 90 tablet in 1 bottle, plastic | 29300-168-19 | Unichem LaboratoriesIndia | 6 January 2023 |
| 30 tablet in 1 bottle | 72578-096-06 | Viona PharmaceuticalsIndia | 4 March 2021 |
| 1000 tablet in 1 bottle | 72578-096-10 | Viona PharmaceuticalsIndia | 4 March 2021 |
| 150 tablet in 1 bottle | 72578-096-21 | Viona PharmaceuticalsIndia | 4 March 2021 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 72578-096-77 | Viona PharmaceuticalsIndia | 4 March 2021 |
| 1000 tablet in 1 bottle | 70771-1335-0 | Zydus LifesciencesIndia | 13 September 2018 |
| 30 tablet in 1 bottle | 70771-1335-3 | Zydus LifesciencesIndia | 13 September 2018 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70771-1335-4 | Zydus LifesciencesIndia | 13 September 2018 |
| 150 tablet in 1 bottle | 70771-1335-8 | Zydus LifesciencesIndia | 13 September 2018 |
| 100 tablet in 1 bottle | 60505-0251-1 | Apotex | 16 January 2004 |
| 1000 tablet in 1 bottle | 60505-0251-2 | Apotex | 16 January 2004 |
| 150 tablet in 1 bottle | 60505-0251-3 | Apotex | 16 January 2004 |
| 60 tablet in 1 bottle | 82461-720-60 | Medcore | 10 April 2026 |
| 30 tablet in 1 bottle | 64980-658-03 | Rising Pharma Holdings | 15 December 2024 |
| 1000 tablet in 1 bottle | 64980-658-10 | Rising Pharma Holdings | 15 December 2024 |
| 150 tablet in 1 bottle | 64980-658-15 | Rising Pharma Holdings | 15 December 2024 |
| 1000 tablet in 1 bottle | 63629-2370-1 | Bryant Ranch Prepack | 18 February 2021 |
| 40 tablet in 1 bottle | 63629-3209-0 | Bryant Ranch Prepack | 8 December 2021 |
| 30 tablet in 1 bottle | 63629-3209-1 | Bryant Ranch Prepack | 24 August 2007 |
| 60 tablet in 1 bottle | 63629-3209-2 | Bryant Ranch Prepack | 25 April 2007 |
| 90 tablet in 1 bottle | 63629-3209-3 | Bryant Ranch Prepack | 6 March 2007 |
| 120 tablet in 1 bottle | 63629-3209-4 | Bryant Ranch Prepack | 17 September 2008 |
| 100 tablet in 1 bottle | 63629-3209-5 | Bryant Ranch Prepack | 13 October 2008 |
| 84 tablet in 1 bottle | 63629-3209-6 | Bryant Ranch Prepack | 4 March 2010 |
| 28 tablet in 1 bottle | 63629-3209-7 | Bryant Ranch Prepack | 4 March 2010 |
| 21 tablet in 1 bottle | 63629-3209-8 | Bryant Ranch Prepack | 17 November 2010 |
| 160 tablet in 1 bottle | 63629-3209-9 | Bryant Ranch Prepack | 1 August 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 November 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tizanidine
Clinical summary
Tizanidine is a central alpha-2 adrenergic agonist indicated for the treatment of spasticity in adults. It is available as tablets, capsules and oral solution. MedsAcross supplies Tizanidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TizanidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zanaflex prescribing information (Legacy Pharma) · U.S. National Library of Medicine, DailyMed
Need Tizanidine 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.